Breaking

‘Number of people killed’ after car drives into crowd at Vancouver Filipino festival
Pope Francis used WhatsApp to stay connected to torture survivor of Argentina’s ‘Dirty War’
Iran tight-lipped on cause of deadly port explosion amid reports of possible presence of chemicals used to fuel missiles
Russian military turns to motorbikes to evade Ukrainian drones on frontlines
Israeli airstrike rocks southern Beirut after military issues evacuation warning
Canadian Filipinos mourn after car ramming attack on their community. Here’s what we know
Defunding DEI: Here’s how the Trump administration has undone Biden’s very prized programs
Waltz doubles down on Hegseth praise amid ongoing Pentagon controversy

Politics
World
Investing
Business
Search for:

Investing

First patient dosed in Phase IIb imaging for Brain Mets

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

RHI: Acqn of royalty over Sandstone Gold Project tenements

Editor’s Picks: Gold Price Touches US$3,500 in Volatile Week, M&A Heats Up

Binding Commitments Received for A$1.0 Million under Convertible Note Placement

Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!

Your name
Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (1,241)
- Investing (2,907)
- Politics (3,888)
- World (3,763)

Disclaimer: FinancesDataDriven.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest Posts

Copyright © 2025 financesdatadriven.com | All Rights Reserved

Top

Politics
World
Investing
Business

Type above and press Enter to search. Press Esc to cancel.